S EL Hadad

Research Center of Genetic Engineering and Bioinformatics, VACSERA, Cairo, Egypt

Publications

  • Research   
    Is Superantigen a Promising Immunotherapy Treatment Against Cancer?
    Author(s): S Al Zahrani and S EL Hadad*

    Superantigens are toxins produced in hosts by some pathogenic microbes as a mechanism to sustain their pathogenicity. Superantigens are highly resistant to degradation by proteases enzyme and heat denaturation and cause many dangerous diseases that in severe cases lead to death. Superantigens are atypical antigens that stimulate a profound proliferation of polyclonal T cells at low concentrations. All superantigens have a standard architecture even though they differ in amino acid sequences and are divided into two groups: endogenous superantigens and exogenous superantigens. The major histocompatibility complex molecules on antigen-presenting cells and T cell receptors on T cells are the major players in identifying foreign antigens. Superantigens can bind nonspecifically to both the major histocompatibility complex class II molecules and T cell receptors and form a trimolecular comp.. Read More»

    Abstract HTML PDF